Live
ePaper
Search
Live ePaper

Copyright 2025 - All Right Reserved.
ITV Network Ltd 2025

Home > India > BRIEF-GSK Reports 61% Overall Response Rate For Ris-Rez In Phase IB Trial

BRIEF-GSK Reports 61% Overall Response Rate For Ris-Rez In Phase IB Trial

Written By:
Last Updated: October 19, 2026 03:48:36 IST

Follow us on
Google News

Share

Oct 18 (Reuters) – GSK plc: * GSK – REPORTS 61% OVERALL RESPONSE RATE FOR RIS-REZ IN PHASE IB TRIAL Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Anthropic to commit 5% stake to new 'public benefit fund'
UPDATE 9-NFL Standings
BRIEF-Daiichi Life Group, Inc. – Confirms That Tda Has Submitted A Non-Binding Proposal To The Board Of Directors Of Challenger
Japan's Daiichi Life unit tables offer to take over Australia's Challenger
Tyler Reddick uses bold move to win Freeway Insurance 500
Austrian Airlines flight from Tel Aviv makes emergency landing after bomb threat, Sky News reports
Oil slips as Trump's sanction waiver may lead to more Russian fuel supplies
Brookfield's $2.53 billion bid for Reliance Worldwide clears 'go shop' hurdle
Oil slips as Trump's sanction waiver may lead to more Russian fuel supplies
FLIGHT FROM TEL AVIV TO VIENNA MAKES EMERGENCY LANDING AFTER BOMB THREAT- SKY NEWS

Follow Us

Facebook Twitter Youtube Instagram

India News : Find Latest India News and Breaking News from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and more.

मुख्य श्रेणियाँ

Follow Us

Facebook Twitter Youtube Instagram

India News : Find Latest India News and Breaking News from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and more.

मुख्य श्रेणियाँ

Group Websites

QUICK LINKS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?